Cognitive performance and capacity to return home following out-of-hospital cardiac arrest

por Petrie, J, Lockie, C, Brett, S, Stümpfle, R
Publicado 2013

The fifty-nine icosahedra

por Coxeter, H S M, Val, P, Flather, H T, Petrie, J F
Publicado 1982

Hospital costs of out-of-hospital cardiac arrest patients treated in intensive care; a single centre evaluation using the national tariff-based system

por Petrie, J, Easton, S, Naik, V, Lockie, C, Brett, S J, Stümpfle, R
Publicado 2015

Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?

por Cleland, S. J., Fisher, B. M., Colhoun, H. M., Sattar, N., Petrie, J. R.
Publicado 2013

Lithium ion irradiation of standard and oxygenated silicon diodes

por Candelori, A, Betta, G F D, Bisello, D, Giubilato, P, Kaminski, A, Litovchenko, A P, Lozano, A, Petrie, J R, Rando, R, Ullán, M, Wyss, J
Publicado 2004

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

por Masmiquel, L., Leiter, L. A., Vidal, J., Bain, S., Petrie, J., Franek, E., Raz, I., Comlekci, A., Jacob, S., van Gaal, L., Baeres, F. M. M., Marso, S. P., Eriksson, M.
Publicado 2016

Pre-hospital prediction of adverse outcomes in patients with suspected COVID-19: Development, application and comparison of machine learning and deep learning methods

por Hasan, M., Bath, P.A., Marincowitz, C., Sutton, L., Pilbery, R., Hopfgartner, F., Mazumdar, S., Campbell, R., Stone, T., Thomas, B., Bell, F., Turner, J., Biggs, K., Petrie, J., Goodacre, S.
Publicado 2022

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

por Colhoun, H. M., Livingstone, S. J., Looker, H. C., Morris, A. D., Wild, S. H., Lindsay, R. S., Reed, C., Donnan, P. T., Guthrie, B., Leese, G. P., McKnight, J., Pearson, D. W. M., Pearson, E., Petrie, J. R., Philip, S., Sattar, N., Sullivan, F. M., McKeigue, P.
Publicado 2012

Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial

por Petrie, John R., Chaturvedi, Nish, Ford, Ian, Hramiak, Irene, Hughes, Alun D., Jenkins, Alicia J., E. Klein, Barbara, Klein, Ron, Ooi, Teik Chye, Rossing, Peter, Sattar, Naveed, Stehouwer, Coen D. A., Colhoun, Helen M., Ford, I, Kean, S, Thomson, E, Gillespie, L, Gibb, J, Greenlaw, N, Hramiak, I, Keech, A, Jenkins, A, Chaturvedi, N, Hughes, A, March, K, Coady, E, Tillin, T, Bots, M, Klein, R, Klein, B, Dreyer, J, Jan, T, Meuer, S, Murach, D, Sheffy, Koby, Lusky, Ravit, Peleg, S, Petrie, J, Colhoun, H, Shore, A, Carty, D, Donnan, P, Witham, M, Adler, A, Lonn, E, Rauchhaus, P, Hramiak, I, Lindsay, R, Brouwers, M, Van‐Melckebeke, J, Gillespie, L, Hamill, T, Cuthbertson, L, Murray, A, Jolly, L, Miller, E, Sattar, N, Hair, J, Bell, A, Carmichael, S, Douglas, E, Surtees, P, Dinnett, E, Allan, J, Kean, S, Watson, C, McLaughlin, M, Brindley, G, Smillie, E, Motherwell, D, MacDonald, S, Ellis, P, Stuart, D, Travers, M, Brearley, S, Greig, L, Haw, J
Publicado 2017